Vontobel Financial Products GmbH Share Price

Certificat

DE000VM05B94

Market Closed - Deutsche Boerse AG 19:02:09 28/06/2024 BST
100.8 EUR +0.24% Intraday chart for Vontobel Financial Products GmbH
Current month-0.64%
1 month-0.49%
Date Price Change
28/06/24 100.8 +0.24%
27/06/24 100.5 -0.22%
26/06/24 100.8 +0.03%
25/06/24 100.7 -0.06%
24/06/24 100.8 +0.27%

Delayed Quote Deutsche Boerse AG

Last update June 28, 2024 at 07:02 pm

More quotes

Static data

Product typeReverse Convertibles
Buy / SellCALL
Underlying SANOFI
IssuerLogo Issuer Vontobel Vontobel
WKN VM05B9
ISINDE000VM05B94
Date issued 04/09/2023
Strike 98.03
Maturity 20/09/2024 (83 Days)
Parity 0.1 : 1
Emission price 100
Emission volume N/A
Settlement both
Currency EUR

Technical Indicators

Highest since issue 103.3
Lowest since issue 94.05

Company Profile

Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Sector
-
More about the company

Ratings for Sanofi

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Sanofi

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
89.94 EUR
Average target price
107.9 EUR
Spread / Average Target
+19.93%
Consensus